About Aragen Bioscience
Aragen Bioscience is a company based in Morgan Hill (United States) founded in 1993 was acquired by Aragen in January 2014. Aragen Bioscience offers products and services including Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing. Aragen Bioscience operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- InvestorsGoldman Sachs
& 3 more
- Acquired byAragen
(Jan 2014)
Products & Services of Aragen Bioscience
Aragen Bioscience offers a comprehensive portfolio of products and services, including Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing.
Service for developing stable cell lines for biopharmaceutical research.
Process for expressing and purifying proteins for therapeutic applications.
Laboratory services for analyzing biologics quality and efficacy.
Testing protocols for evaluating drug candidates in animal models.
Apps and channels of Aragen Bioscience
its YouTube channel Aragen Life Sciences has 669 subscribers and 22 videos.
Videos from Aragen Bioscience
The most watched videos on Aragen Bioscience's YouTube channel, Aragen Life Sciences (669 subscribers). Click a video to play it here.
More on Aragen Life Sciences.
Funding Insights of Aragen Bioscience
- Total Rounds 2
- Investors Count 3
All 2 funding rounds of Aragen Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | – | Series C | – | – | |
| Sep 2018 | – | Series B | – | – |
4 investors in total: 4 institutional.
Investors in Aragen Bioscience
Aragen Bioscience has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Aragen Life Sciences and Oxford University Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Investment management services for science ventures are provided in Oxford. | – | oxfordscienceenterprises.com | Oxford, United Kingdom | |
Startups are incubated by Oxford University Innovation. | 1987 | innovation.ox.ac.uk | Oxford, United Kingdom | |
Aragen Life Sciences is engaged in contract research and manufacturing for pharmaceuticals. | 2001 | aragen.com | Hyderabad, India |
Investor details for Aragen Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aragen Bioscience
4 dated milestones of Aragen Bioscience across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Aragen Bioscience is founded.
- Exit Acquired by Aragen.
- Funding First funding round.
- Funding Latest funding round, Series C,.
Competitors of Aragen Bioscience
Aragen Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evotec.com | 1993 | Hamburg, Germany | $25M | 252 | Drug discovery and development services are provided to biopharma sector. | |
| crownbio.com | 2006 | Santa Clara, United States | $85.87M | 18 | Cancer and CVMD drugs are developed using PDX models. | |
| alloytx.com | 2017 | Lexington, United States | $117M | – | Drug discovery services are provided for therapeutic development. | |
| catsci.com | 2010 | Cardiff, United Kingdom | $5.89M | 63 | Drug discovery services are provided to pharmaceutical clients worldwide. | |
| nih.gov | 1887 | United States | – | – | Drug discovery services are provided to the biopharma sector. | |
| domainex.co.uk | 2001 | Cambridge, United Kingdom | $4.97M | 93 | Drug discovery CRO company for epigenetic research and inflammatory diseases | |
| vivabiotech.com | 2006 | Shanghai, China | – | – | Drug discovery and development research services are provided. | |
| superluminalrx.com | 2022 | Boston, United States | $158M | – | Generative biological and chemical solutions are applied to drug discovery. | |
| newlimit.com | 2022 | San Francisco, United States | $202.25M | 9 | Developer of epigenetic reprogramming medicines for aging-related diseases and healthspan extension | |
| qyuns.net | 2015 | Taizhou, China | $66.35M | – | Drug development services are provided to the biopharma sector. |
Detailed competitors of Aragen Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aragen Bioscience
The website of Aragen Bioscience (aragenbio.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 10.5% vs previous month
Websites whose visitors overlap most with Aragen Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biolifesolutions.com | 100% | 19.3K | #1,303,380 | View details | |
| essenbioscience.com | 93% | 1.2K | #11,418,683 | View details | |
actionbioscience.org | actionbioscience.org | 92% | – | – | – |
aboutbioscience.org | aboutbioscience.org | 92% | – | – | – |
| trilinkbiotech.com | 80% | 29.9K | #920,436 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Aragen Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Aragen Bioscience
Complete news archive for Aragen Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Aragen Bioscience
10 companies that operate in the same segment as Aragen Bioscience (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aragen Bioscience
Aragen Bioscience was founded in 1993 and raised its 1st funding round 25 years after it was founded.
Aragen Bioscience is headquartered in Morgan Hill, United States. It is registered at Morgan Hill, California, United States.
Aragen Bioscience was established in 1993 as a contract research organization based in Morgan Hill, United States. Operations focus on the biotech and pharmaceutical sectors, with services encompassing cell line development, protein expression and purification, molecular biology, immunology, and both in vitro and in vivo efficacy assessments for biologic and diagnostic products. Early development support is extended through these integrated capabilities.
Aragen Bioscience's top competitors include Evotec, Crown Bioscience and NIH.
Aragen Bioscience offers Cell Line Development, Protein Expression, Analytical Services, and Preclinical Efficacy Testing.
Aragen Bioscience has 4 investors. Key investors include Goldman Sachs, Aragen Life Sciences, Oxford University Innovation, and Oxford Science Enterprises.
Yes. Aragen Bioscience was acquired by Aragen in January 2014.